Sputnik V vaccine production, Gamaleya Institute, Moscow

Second interim analysis of clinical trial data showed a 91.4% efficacy for the #SputnikV vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose. Facebook: Instagram: Twitter: WEBSITE: